EMA Withdrawn: Fertavid (follitropin beta) — Merck Sharp & Dohme B.V.

View source ↗

Summary

Fertavid (follitropin beta) has been withdrawn from EMA status by Merck Sharp & Dohme B.V. with no remaining active medicinal products.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Infertility

Drugs mentioned

• Fertavid (follitropin beta)

Snippet

Status: Withdrawn. Therapeutic area: Infertility;Hypogonadism. MAH: Merck Sharp & Dohme B.V.. Decision date: 20/01/2020